Rebalix
Logo XtrackersXtrackers · sheet of 10 September 2026
ETF sheet · official issuer and register data

Xtrackers Switzerland UCITS ETF 1d

LU0274221281 · LU0274221281 · CHF · domicile Luxembourg
Equity · Switzerland · Large capSFDR art. 6 (inferred)
Index tracked: Solactive Swiss Large Cap Index (NTR) (CHF)
TER
0.30%+ trans. 0.01%
Fund size
2.5 bn EUR
Tracking difference
−0.26%3-year avg
🇮🇹 tax rate
white list not published
Replication
Physical
Income
Distributingannual
Launch 22 Jan 2007 · costs from the KID as of 2 Sept 2026 · 23 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed. INVESTMENT OBJECTIVE: The aim is for your investment to reflect the performance of the Solactive Swiss Large Cap index (NTR) (index) which is designed to reflect the performance of shares of the 20 largest companies domiciled and listed in Switzerland. DESCRIPTION OF INDEX: The companies represented in the index are selected on the basis of the combined value of their shares as compared to other companies on the stock exchange. The largest company can make up no more than 32.5% of the index and all other companies…

Performance since series start (in euro) — base 100

15 Jan 20078 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
200820112014201720202023202640955390
High 409 (10 Aug 2026) · low 55 (6 Mar 2009) · last 390. Past performance is not indicative of future results.

Returns in euro

1 year+15.8%
3 years+35.6%
5 years+40.7%
10 years+131.9%
Since series start+289.9%

Risk · 1 / 3 / 5 years

Volatility (ann.)11.94%12.63%13.30%
Max drawdown−11.55%−16.51%−23.08%
Sharpe1.030.450.05
Sortino1.500.600.07
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU0274221281 · LU02742212811
RebalixLU0274221281 · LU0274221281 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+17.31%+17.61%−0.30%
2024+5.14%+5.40%−0.27%
2023+5.00%+5.21%−0.21%
2022−16.10%−15.91%−0.19%
2021+21.98%+22.27%−0.29%

Distributions · per share, in CHF

Frequency: annual · last 12 months: 2.2239 CHF (1.53% of NAV) · last ex-date 19 Aug 2026
YearPaymentsTotal (CHF)Dividend yield
202612.2239
202512.1023+1.78%
202411.9524+1.71%
202312.0568+1.86%
202223.6639+2.69%
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.

Holdings

Portfolio as declared by the issuer · 2 Sept 2026 · 23 securities · top-10 weight = 82.9%
Top holdingsWeight
ROCHE PS PAR AG16.4%
NOVARTIS AG15.7%
NESTLE SA13.3%
UBS GROUP AG8.9%
ABB LTD8.1%
COMPAGNIE FINANCIERE RICHEMONT SA6.6%
ZURICH INSURANCE GROUP AG6.0%
SWISS RE AG2.8%
LONZA GROUP AG2.7%
HOLCIM LTD AG2.4%
Countries (% of fund)
Switzerland100.0%
Sectors (% of fund)
Pharmaceuticals, Biotechno…38.8%Food, Beverage & Tobacco13.3%Insurance11.6%Capital Goods10.4%Financial Services8.9%

Listing venues

ESMA register (FIRDS) and official exchange lists
XSMI · Borsa Italiana (ETFplus), Xetra (Deutsche Börse)
· Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
+ 25 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · etf.dws.com/download/asset/ce56bf96-9acc-4865-a047-165357b74bd8
Factsheet · etf.dws.com/download/asset/3972522b-8fc5-496d-b06b-34301868b5ce
Prospectus · etf.dws.com/download/asset/97f28cea-2f24-445d-b135-f9c31a5f884d
The live sheet, always up to date
rebalix.com/en/etf/LU0274221281
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · LU0274221281 · LU02742212812